Myriad Genetics Chief Financial Officer Bryan Riggsbee Retires; Scott Leffler Appointed As Successor; Reiterates Previously Issued Financial Guidance
Myriad Genetics Chief Financial Officer Bryan Riggsbee Retires; Scott Leffler Appointed As Successor; Reiterates Previously Issued Financial Guidance
12/21/23, 1:32 PM
Location
Industry
genetics
health diagnostics
medical
health care
biotechnology
Myriad Genetics, Inc., , a leader in genetic testing and precision medicine, today announced the appointment of Scott Leffler as Chief Financial Officer , effective January 29, 2024. Leffler will succeed Myriad CFO Bryan Riggsbee who is retiring. Riggsbee will continue as a strategic advisor through March 31, 2024, to ensure a smooth transition.
Company Info
Location
322 north 2200 west
salt lake city, utah, united states
Additional Info
Myriad Genetics is a leading genetic testing and precision medicine company dedicated to advancing health and well-being for all. Myriad develops and offers genetic tests that help assess the risk of developing disease or disease progression and guide treatment decisions across medical specialties where genetic insights can significantly improve patient care and lower healthcare costs.
Related People

Unlock Verified Contacts + AI Outreach
Instantly access verified contact emails — and let Fundz AI draft a hyper-personalized message based on their role, company, and your company's offering.
Gh
Gh • Executive
Email hidden • Upgrade to unlock
Trusted by teams at Google, Oracle, HubSpot & more

Unlock Verified Contacts + AI Outreach
Instantly access verified contact emails — and let Fundz AI draft a hyper-personalized message based on their role, company, and your company's offering.
Bh
Bh • Executive
Email hidden • Upgrade to unlock
Trusted by teams at Google, Oracle, HubSpot & more